Cargando…

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the causative factor behind the 2019 global coronavirus pandemic (COVID-19). The main protease, known as M(pro), is encoded by the viral genome and is essential for viral replication. It has also been an effective target for drug de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kronenberger, Thales, Laufer, Stefan A., Pillaiyar, Thanigaimalai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Keynote
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074736/ https://www.ncbi.nlm.nih.gov/pubmed/37028502 http://dx.doi.org/10.1016/j.drudis.2023.103579

Ejemplares similares

Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016)

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
por: Geiger, Nina, et al.
Publicado: (2023)

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)

Search of Novel Small Molecule Inhibitors for the Main Protease of SARS-CoV-2
por: Zhang, Wenfa, et al.
Publicado: (2023)

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
por: Breidenbach, Julian, et al.
Publicado: (2021)

Building Power Between Polarities: On the Space-in-Between
por: Ventres, William B.
Publicado: (2016)

Having seen it all: my vision of atrial fibrillation treatment in 2022
por: Cox, James L
Publicado: (2018)

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
por: Heida, Rick, et al.
Publicado: (2021)

Keynotes
Publicado: (2023)

In Silico Discovery of Small-Molecule Inhibitors Targeting SARS-CoV-2 Main Protease
por: Gao, Menghan, et al.
Publicado: (2023)

The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors
por: Silvestrini, Lucia, et al.
Publicado: (2021)

The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020)

Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands
por: Zlotos, Darius P., et al.
Publicado: (2022)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021)

Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
por: Milligan, Jennifer C., et al.
Publicado: (2021)

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
por: Choudhury, Chinmayee, et al.
Publicado: (2022)

Activation and maturation of SARS-CoV main protease
por: Xia, Bin, et al.
Publicado: (2011)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Hattori, Shin-ichiro, et al.
Publicado: (2021)

Small molecule co-solvents enhance activity of SARS-CoV-2 main protease through a dielectric effect
por: Crosby, Marquise G.
Publicado: (2023)

Impact of Drug Repurposing on SARS-Cov-2 Main Protease
por: Ndagi, Umar, et al.
Publicado: (2023)

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
por: Tripathi, Praveen Kumar, et al.
Publicado: (2020)

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
por: Ghahremanpour, Mohammad M., et al.
Publicado: (2020)

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Topological analysis of SARS CoV-2 main protease
por: Estrada, Ernesto
Publicado: (2020)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Allosteric Hotspots in the Main Protease of SARS-CoV-2
por: Strömich, Léonie, et al.
Publicado: (2022)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

Automated discovery of noncovalent inhibitors of SARS-CoV-2 main protease by consensus Deep Docking of 40 billion small molecules
por: Gentile, Francesco, et al.
Publicado: (2021)

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
por: Sanachai, Kamonpan, et al.
Publicado: (2022)

The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
por: Sacco, Michael Dominic, et al.
Publicado: (2022)

AI-Driven De Novo Design and Molecular Modeling for Discovery of Small-Molecule Compounds as Potential Drug Candidates Targeting SARS-CoV-2 Main Protease
por: Andrianov, Alexander M., et al.
Publicado: (2023)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
por: Baby, Krishnaprasad, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rcvn9il7tmrodsva0dl564fveh